Swedish Prostate Cancer Initiative for Novel Treatment Regimens - Real, Implementation of Precision Medicine in High-risk Prostate Cancer
Status: Recruiting
Location: See location...
Intervention Type: Radiation, Other, Procedure, Drug
Study Type: Observational
SUMMARY
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Men investigated for suspected prostate cancer
• Signed consent form
Locations
Other Locations
Sweden
Urology, Umeå University Hospital, Region Västerbotten
RECRUITING
Umeå
Contact Information
Primary
Andreas Josefsson, MD, PhD
andreas.josefsson@umu.se
+46 907850000
Backup
Karin Welen, PhD
karin.welen@urology.gu.se
Time Frame
Start Date: 2024-06-10
Estimated Completion Date: 2054-12
Participants
Target number of participants: 5500
Treatments
Non-metastatic high-risk prostate cancer
ISUP ≥4, T3-4, or regional lymph node positive
Low risk prostate cancer
ISUP = 1, PSA \<10 µg/L, PSA-density \<0,15 µg/l/cm3
Medium risk prostate cancer
ISUP 2-3, PSA 10-20 µg/L
Metastatic prostate cancer
PSA \> 80 µg/L, clinically manifest metastases
Related Therapeutic Areas
Sponsors
Collaborators: Umeå University
Leads: Andreas Josefsson